Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COR
401
DELISTED
Coresite Realty Corporation
COR
| $52.5M | 0.07% |
523,924
+34,708
| +7% | +$3.55M |
|
402
Petrobras
PBR
$123B
| $52.4M | 0.07% |
3,706,067
-987,250
| -21% | -$13M |
|
403
BioMarin Pharmaceuticals
BMRN
$12.9B
| $52.3M | 0.07% |
645,400
+10,536
| +2% | +$904K |
|
404
Dollar General
DG
$27.2B
| $52.3M | 0.07% |
559,195
+465,720
| +498% | +$44.8M |
|
|
RDUS
405
DELISTED
Radius Health, Inc.
RDUS
| $52.3M | 0.07% |
1,454,129
-395,674
| -21% | -$14.3M |
|
|
HPP
406
Hudson Pacific Properties
HPP
$787M
| $52M | 0.07% |
228,429
-213,737
| -48% | -$47.5M |
|
407
ManpowerGroup
MAN
$2.86B
| $51.9M | 0.07% |
450,557
+283,264
| +169% | +$35M |
|
408
CALL
Spectrum Brands
SPB
$2B
| $51.9M | 0.07% |
+500,000
| New | +$53.8M |
|
|
EE
409
DELISTED
El Paso Electric Company
EE
| $51.8M | 0.07% |
1,016,531
+319,407
| +46% | +$16.2M |
|
410
Edison International
EIX
$27.5B
| $51.8M | 0.07% |
813,867
+335,067
| +70% | +$20.6M |
|
411
Howard Hughes
HHH
$3.97B
| $51.7M | 0.07% |
390,064
+205,253
| +111% | +$25.2M |
|
|
P
412
Everpure Inc
P
$36.1B
| $51.7M | 0.07% |
2,590,785
+172,897
| +7% | +$3.39M |
|
413
QuidelOrtho
QDEL
$1.01B
| $51.6M | 0.07% |
996,815
+417,106
| +72% | +$19.4M |
|
414
MGIC Investment
MTG
$6.34B
| $51.5M | 0.07% |
3,965,395
-656,546
| -14% | -$9.3M |
|
|
CADE
415
DELISTED
Cadence Bancorporation
CADE
| $51.5M | 0.07% |
1,890,296
+907,492
| +92% | +$25.3M |
|
416
Tenet Healthcare
THC
$22.6B
| $51.1M | 0.07% |
2,109,113
+614,701
| +41% | +$12.2M |
|
417
Zebra Technologies
ZBRA
$17.4B
| $50.9M | 0.07% |
365,994
+250,125
| +216% | +$32M |
|
|
DISCK
418
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $50.9M | 0.07% |
+2,605,557
| New | +$58.3M |
|
419
Nutrien
NTR
$35.9B
| $50.7M | 0.07% |
+1,073,119
| New | +$53.7M |
|
|
NVRO
420
DELISTED
NEVRO CORP.
NVRO
| $50.7M | 0.07% |
584,529
+539,948
| +1,211% | +$43.6M |
|
421
Amphenol
APH
$194B
| $50.4M | 0.07% |
2,341,048
+586,240
| +33% | +$13.2M |
|
|
DRE
422
DELISTED
Duke Realty Corp.
DRE
| $50.3M | 0.07% |
1,900,685
-558,600
| -23% | -$14.4M |
|
423
Douglas Emmett
DEI
$1.97B
| $50.3M | 0.07% |
1,368,084
+386,068
| +39% | +$14.5M |
|
424
International Bancshares
IBOC
$4.45B
| $49.9M | 0.07% |
1,282,237
+141,671
| +12% | +$5.75M |
|
|
EVHC
425
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $49.5M | 0.07% |
1,287,524
+1,028,766
| +398% | +$38.4M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.